Comtan Footer
For U.S. residents only Non-U.S. residents Novartis Pharma US
    Learn About Novartis
   
ABOUT STALEVO

 

 

 

 

For patients with Parkinson's disease (PD) experiencing symptom
reemergence due to "wearing off," STALEVO does more than carbidopa/levodopa alone
 
STALEVO has been clinically proven to deliver more active time during the day—almost an hour and a half each day (1.4 hours). So you can enjoy more time with fewer symptoms.

If a health care professional prescribed STALEVO for you or someone you care for, find out more about it. STALEVO.com is a good place to find answers to questions, such as:
 
 
Look into insurance and assistance with STALEVO.
 
 
 
 
 
 
     
Get information for care partners of people taking STALEVO
 
Learn More
 
   
 
 
      Stalevo
 
 
   
Orion Pharma  
 
 
 
Novartis Use of website is governed by the Terms of Use and Privacy Statement.
Copyright ©2010 Novartis Pharmaceuticals Corporation. All rights reserved.
 
3/10 - SLV-900358